Pancreatic enzyme replacement therapy for enterally fed patients with cystic fibrosis

Nutr Clin Pract. 2013 Aug;28(4):485-9. doi: 10.1177/0884533613491786. Epub 2013 Jun 10.

Abstract

Administration of pancreatic enzymes (pancrelipase) to adult patients with cystic fibrosis when receiving enteral nutrition through a feeding tube is challenging. A number of techniques for preparing and administering the drug may result in complications that include feeding tube occlusion and inadequate enzyme delivery to the patient. A series of inpatient encounters is described.

Keywords: cystic fibrosis; enteral nutrition; enzymes; food-drug interactions; pancreas.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / enzymology
  • Cystic Fibrosis / therapy*
  • Enteral Nutrition / adverse effects
  • Enteral Nutrition / methods*
  • Enzyme Replacement Therapy*
  • Exocrine Pancreatic Insufficiency / drug therapy*
  • Exocrine Pancreatic Insufficiency / etiology
  • Female
  • Humans
  • Male
  • Pancrelipase / administration & dosage
  • Pancrelipase / therapeutic use*
  • Young Adult

Substances

  • Pancrelipase